RXRG
RXRG (retinoid X receptor gamma, also known as NR2B3 and RXR-gamma) is a nuclear hormone receptor that binds retinoic acid and regulates gene expression. It acts as a heterodimer partner for other nuclear receptors on their DNA response elements. Browse Assay Genie's current range of RXRG research reagents below, or read on for the biology behind the target.
RXRG is a receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers recognise retinoic acid response elements (RARE), which are composed of tandem 5'-AGGTCA-3' sites arranged as DR1 to DR5. The high-affinity ligand for the RXRs is 9-cis retinoic acid.
The RXRG gene encodes a member of the retinoid X receptor (RXR) family of nuclear receptors, which are involved in mediating the antiproliferative effects of retinoic acid. The receptor forms dimers with the retinoic acid, thyroid hormone and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. The protein belongs to the nuclear hormone receptor family, NR2 subfamily, and is found in the nucleus and the cytoplasm. Alternatively spliced transcript variants have been described.
RXRG is classed by HGNC in the retinoid X receptors gene group and was previously named retinoid X receptor, gamma. The mouse and rat orthologs are both designated Rxrg. In disease-related context, the gene is expressed at significantly lower levels in non-small cell lung cancer cells, which makes the RXR gamma protein of interest for studies of retinoid signalling in cancer.
RXRG is a retinoic acid receptor that regulates gene expression in response to all-trans and 9-cis retinoic acid.
It forms dimers with retinoic acid, thyroid hormone and vitamin D receptors, enhancing DNA binding and transcriptional function.
RXRG is expressed at significantly lower levels in non-small cell lung cancer cells, linking it to altered retinoid responses.
RAR/RXR heterodimers bind DR1 to DR5 response elements built from tandem 5'-AGGTCA-3' sites, a model for ligand-dependent gene control.
RXRG is a receptor for retinoic acid. It binds as a heterodimer to retinoic acid response elements in response to all-trans or 9-cis retinoic acid and regulates gene expression. It also dimerises with thyroid hormone and vitamin D receptors, increasing their DNA binding and transcriptional function.
RXRG is also called NR2B3, RXRgamma and RXR-gamma. The full name is retinoid X receptor gamma, and the UniProt protein name is retinoic acid receptor RXR-gamma. An earlier HGNC name was retinoid X receptor, gamma. Alternatively spliced transcript variants have been described.
Mouse and rat both have an ortholog named Rxrg; check the datasheet of any product for its validated reactivity. The human gene is expressed at significantly lower levels in non-small cell lung cancer cells, according to the NCBI Gene summary.
Other retinoid X receptors, retinoic acid receptors and dimerisation partners such as the vitamin D and thyroid hormone receptors.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P48443; product specifications from Assay Genie datasheets.